Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up since Jun 10 · below the Ichimoku cloud · RSI 45 · MACD below its signal
| 303.00 | 52-week high | +3577.18% |
| 10.74 | Previous week high | +30.34% |
| 9.90 | Previous month high | +20.15% |
| 8.97 | R3 (classic) | +8.86% |
| 8.97 | R2 (classic) | +8.86% |
| 8.97 | R1 (classic) | +8.86% |
| 8.97 | Pivot | +8.86% |
| 8.97 | S1 (classic) | +8.86% |
| 8.97 | S2 (classic) | +8.86% |
| 8.97 | S3 (classic) | +8.86% |
| 8.97 | Previous day high | +8.86% |
| 8.97 | Previous day low | +8.86% |
| 8.59 | Previous week low | +4.25% |
| 8.24 | Price now | |
| 6.90 | Previous month low | −16.26% |
| 6.45 | 52-week low | −21.72% |
None of the 29 investors followed here reported a position in BGM in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a BGM trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for BGM.
TimeframesDown on the hourly, weekly and monthly, mixed on the daily.
under a falling 21 EMA, 21 under 50
pulling back under the 21 EMA
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.3 | -68.6 | -72.7 | -3.3 | 8.2 | 16.1 | -23.4 | -3.5 | -7.4 | 9.0 | −92.6% | ||
| 2025 | 8.9 | 3.0 | 20.7 | -2.8 | 20.4 | -20.9 | -20.1 | -11.2 | 36.4 | -7.6 | -18.6 | -52.1 | −56.3% |
| 2024 | -28.9 | -23.4 | 64.3 | 6.4 | 9.0 | -16.9 | 86.0 | 12.8 | 14.6 | -12.4 | 26.0 | -4.2 | +119.2% |
| 2023 | 132.7 | -21.6 | -4.0 | -11.2 | -21.7 | -3.3 | -3.1 | -5.6 | -1.1 | -40.9 | -1.9 | 69.1 | +4.3% |
| 2022 | -15.1 | -12.4 | -13.7 | 6.5 | -3.3 | 13.1 | -8.1 | -26.9 | -10.5 | -5.9 | 10.7 | -40.4 | −72.1% |
| 2021 | -20.6 | -15.4 | -1.2 | 2.2 | -10.4 | 1.2 | -3.1 | -2.2 | -7.7 | -18.5 | -12.8 | −61.8% |
No analyst coverage for this instrument.
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a antitussive and expectorant medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, an ingredient for medical preparation companies to produce compound licorice oral solutions. In addition, it offers traditional Chinese medicine derivatives products comprising Ahan antibacterial paste that is used to treat refractory chronic skin diseases; heparin products, including heparin sodium preparation, an ingredient for pharmaceutical companies to produce medications used in treating cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings, such as Zhu Xiaochang sausage casings for culinary purposes. Further, the company provides Fertilizer products comprising Xiongguan organic fertilizers to improve crop yield, increase soil's chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers for plant growth. Additionally, it focuses on the AI-driven commercialization of DuXiaoBao platform to provide comprehensive and professional AI solutions and intelligent robot services for insurance companies, insurance brokers, and consumers. BGM Group Ltd. is based in Chengdu, China.